CVS Group welcomes David Wilton to its Board as Non-Executive Director and announces Deborah Kemp as new Senior Independent Director

– UK, Diss –  CVS Group plc (LON: CVSG), one of the UK’s leading providers of integrated veterinary services, today announced the appointment of David Wilton to its Board as Non-Executive Director with effect from 24 September 2021, replacing Senior Independent Director, Mike McCollum, who is stepping down from the Board on 23 September 2021.

“I would like to welcome David to the Board. He joins at an exciting time in the Company’s evolution and his skills and experience, particularly in people based businesses, will be welcome in support of the finance function but also more broadly as we capitalise on the growth opportunities before us.” said Non-Executive Chairman, Richard Connell.

David has also agreed to serve as Chair of the Audit Committee while Deborah Kemp will take up the role of Senior Independent Non-Executive Director.

About David Wilton

David Wilton is a qualified Chartered Accountant with more than 30 years post qualification experience as a CFO, Non-Executive Director, and consultant after many years in corporate finance, primarily in mid-cap M&A with Rothschilds. David has held roles in both public and private equity-backed companies including as Group Finance Director of WYG plc and as Non-Executive Director and Chair of the Audit Committee of Sweett Group plc. He is currently CFO of Sumo Group plc, the AIM-listed provider of acclaimed development, design and publishing services to the video games and entertainment industries.

For more information: https://www.cvsukltd.co.uk

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.